Private Prescription Comparison: Wegovy vs Mounjaro Dosing
Understanding What 1mg Wegovy Represents in Mounjaro Treatment Plans
When comparing what is 1mg Wegovy in Mounjaro terms, it's essential to understand these are fundamentally different medications with distinct dosing schedules. Wegovy 1mg is prescribed during weeks 9-12 of treatment, representing the third escalation step in the five-stage protocol. Mounjaro doesn't have a direct equivalent to this specific dose, as tirzepatide follows its own escalation pathway starting at 2.5mg weekly. Private prescription access in the UK allows patients to bypass NHS waiting lists, which can extend beyond 6 months for specialist weight management referrals. Through EverydayMeds' GPhC-registered service (#9012878), both treatments are available with professional prescriber review.
The private route offers significant advantages for patients seeking immediate access to these prescription-only medicines. NHS criteria require BMI thresholds plus mandatory specialist referrals through GP gatekeepers, creating substantial delays. Private prescriptions eliminate these barriers whilst maintaining the same clinical safety standards. Our prescribers assess eligibility using identical NICE guidelines, ensuring appropriate candidates receive treatment promptly. This approach particularly benefits patients whose circumstances have changed or those requiring continuity of care without interruption.
Comprehensive Pricing Structure for Private Wegovy and Mounjaro Treatment
Wegovy 1mg costs £99.99 per pen through EverydayMeds, with new customers applying code FIRST40 and returning patients using DOSE25 at checkout to achieve this price. Our Advance Duo bundle pairs 1mg with 1.7mg for £269.99, bridging patients smoothly into the next escalation phase. Mounjaro pricing follows a different structure, reflecting its distinct dosing requirements. When considering what is 1mg Wegovy in Mounjaro equivalent terms, patients should factor in the complete treatment pathway rather than individual dose comparisons. Both medications require long-term commitment for sustained results, making bundle options financially advantageous for treatment continuity.
Private prescription costs reflect the convenience and immediacy of access, eliminating the hidden costs of NHS delays such as continued weight-related health complications or private consultation fees for specialist referrals. Our transparent pricing includes all clinical assessment, prescriber review, and next-day delivery services. No additional consultation fees or membership charges apply beyond the medication cost. Payment plans and subscription services ensure patients maintain consistent treatment without interruption, addressing one of the primary barriers to successful weight management outcomes.
Clinical Evidence Supporting Wegovy 1mg Efficacy in STEP Trials
STEP 1 trial data demonstrates patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, with significant results emerging during the 1mg phase (Wilding et al., NEJM, 2021). The 1mg dose typically represents the point where patients experience established appetite regulation and measurable progress toward their weight management goals. Clinical investigators noted that appetite reduction effects often stabilise during this treatment phase, providing patients with confidence in the medication's efficacy.
Mounjaro's clinical evidence comes from the SURMOUNT trial programme, showing different kinetics due to its dual GIP/GLP-1 mechanism. Both medications have demonstrated cardiovascular benefits in dedicated outcome studies, though direct head-to-head comparisons haven't been conducted. Individual response varies significantly, making prescriber guidance essential when determining what is 1mg Wegovy in Mounjaro equivalent effectiveness for specific patients.
Mechanism of Action: How Wegovy 1mg Supports Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones released after eating. At the 1mg dose, patients typically experience significant appetite reduction and enhanced satiety signals, helping them feel satisfied with smaller portion sizes. The medication works directly on appetite centres in the brain, reducing food cravings and the psychological drive to eat beyond physiological needs. This mechanism differs fundamentally from Mounjaro's dual pathway approach, which targets both GLP-1 and GIP receptors simultaneously. The 1mg dose represents optimal therapeutic effect for many patients whilst maintaining tolerability profiles established during earlier escalation phases. Weekly injection timing ensures consistent medication levels, supporting sustained appetite control throughout treatment.
Streamlined Private Prescription Process for Both Medications
EverydayMeds' private prescription service begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Qualified prescribers review applications using NICE-approved criteria, typically providing decisions within 24 hours through our express service or 3 working days for standard review. Upon approval, medications are dispatched via next-day cold-chain delivery, maintaining optimal storage temperatures throughout transit. Our GPhC-registered pharmacy (#9012878) sources all medications directly from licensed manufacturers, ensuring authenticity and quality standards. Patients receive detailed injection guidance, dose escalation schedules, and ongoing support throughout their treatment journey. No GP referral or specialist consultation is required, eliminating typical NHS barriers whilst maintaining clinical safety standards.
Storage and Practical Considerations for Long-term Treatment Success
Wegovy pens require refrigerated storage at 2-8°C before first use, offering superior travel convenience with 6 weeks room temperature stability once removed from the fridge. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly suitable for patients with active lifestyles or frequent travel commitments. The FlexTouch pen system provides precise dosing with simple injection technique, requiring minimal training for self-administration. Dose escalation from 1mg to 1.7mg occurs at week 13, allowing patients to establish tolerance before progression. When comparing what is 1mg Wegovy in Mounjaro practical terms, storage flexibility often influences patient preference significantly. Regular dose scheduling on the same weekly day optimises treatment consistency and reduces missed injection risks.
Private Prescription Advantages for Wegovy vs Mounjaro Selection
Private prescribing allows detailed consultation about medication selection without time constraints typical of NHS appointments. Prescribers can thoroughly evaluate patient preferences, lifestyle factors, and medical history when determining whether Wegovy or Mounjaro better suits individual circumstances. This personalised approach is particularly valuable when patients ask what is 1mg Wegovy in Mounjaro equivalent terms, as the answer depends on treatment goals, tolerance patterns, and practical considerations. Private prescriptions also enable flexible dose timing adjustments and seamless switching between medications if initial choices prove unsuitable.
The ability to access both medications through the same provider ensures continuity of care and consistent clinical oversight. NHS protocols often limit medication switches due to budget constraints or formulary restrictions, potentially compromising optimal patient outcomes. Private prescription removes these limitations, prioritising clinical effectiveness over cost considerations. Our prescribers maintain detailed treatment records, enabling informed decisions about dose progressions, medication switches, or treatment modifications based on individual response patterns.
Expert Clinical Support and Treatment Optimisation
EverydayMeds' clinical team provides ongoing support throughout treatment, helping patients navigate dose escalations and address any concerns about medication effectiveness or side effects. When patients question what is 1mg Wegovy in Mounjaro effectiveness terms, our prescribers can provide personalised guidance based on individual response patterns and treatment goals. Regular check-ins ensure optimal dose timing and identify opportunities for treatment enhancement through lifestyle modifications. Our GPhC-registered service (#9012878) maintains comprehensive treatment records, enabling evidence-based decisions about medication continuation or switches. Both Wegovy and Mounjaro are available through our platform, giving patients access to the most appropriate prescription-only medicine for their circumstances. Start your private prescription journey today with our streamlined assessment process and next-day delivery service.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
